Current trends in therapy of ocular herpes simplex: experimental and clinical studies.
D000818:Animals; D001088:Arabinonucleotides / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003315:Cornea / Q000378:metabolism; D006147:Guanine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D007065:Idoxuridine / Q000627:therapeutic use; D007635:Keratitis, Dendritic / Q000188:drug therapy*; D009883:Ophthalmic Solutions; D011817:Rabbits; D013936:Thymidine / Q000031:analogs & derivatives*; D014271:Trifluridine / Q000378:metabolism / Q000627:therapeutic use*; D014740:Vidarabine / Q000008:administration & dosage / Q000627:therapeutic use*; D001084:Vidarabine Phosphate / Q000627:therapeutic use*
D001088:Arabinonucleotides; D009883:Ophthalmic Solutions; D001084:Vidarabine Phosphate; D006147:Guanine; D014740:Vidarabine; D007065:Idoxuridine; D014271:Trifluridine; D013936:Thymidine